Previsão

Não temos dados de analistas para esta empresa.

Notícias Ir para o feed de notícias

Guardian Pharmacy buys assets of Nautilus Pharmacy

Guardian Pharmacy is taking over prescription files, pharmacy inventories and certain fixed assets of Tennessee-based Nautilus Pharmacy. Nautilus supplies assisted-living facilities by mail order in 14 US states; Guardian will transition the care of those residents to 18 local Guardian pharmacies in the respective markets. More than half of Nautilus’s employees will be retained, the regional integration will be led by David Brown, and the financial terms of the transaction have been kept confidential. » Mais em de.investing.com
Sigma Healthcare reports strong profit growth, shares fall despite solid results

For the year to June 2026 Sigma Healthcare recorded revenue up 15.5% to AUD 10.8 billion, normalized EBIT of AUD 1.098 billion (+20.6%) and normalized NPAT of AUD 732.3 million (+22.3%). The stock fell about 6.2% as investors highlighted extended cash conversion, integration costs and margin risks from strong GLP-1 category growth. Management reports realized synergies and continued store growth; the company expects ongoing revenue momentum and plans to deliver further synergies through 2029. » Mais em de.investing.com
Sigma Healthcare withdraws from $10 billion bid for Boots

Australia’s Sigma Healthcare has ended early-stage talks to acquire U.K. pharmacy chain Boots, saying the asset no longer fits its strategic priorities and it will focus on Australian and Asian growth. The withdrawal prolongs uncertainty over Boots’ ownership; the chain operates about 1,800 UK stores and has recently been repositioned toward higher-margin beauty and wellness categories. Boots’ owner Sycamore Partners is reported to be considering an IPO as alternatives to a sale continue to be explored. » Mais em forbes.com

Dividendos históricos Dividendos

Todos os indicadores de dividendos Todos os indicadores

Em 2026, Sigma Healthcare já distribuiu € 0,0122 em dividendos. A última distribuição ocorreu em março.

Dados financeiros da empresa

No último trimestre, Sigma Healthcare registou receitas de € 3,23 bi e um ganho líquido de € 199,47 mi

(EUR)	junho de 2026	YoY
Receitas	3,23 bi	-
Ganho bruto	574,79 mi	-
Ganho líquido	199,47 mi	-
EBITDA	300,94 mi	-

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 18,74 bi
Número de ações	11,54 bi
Máximo/mínimo de 52 semanas	€ 1,98 - € 1,59
Rentabilidade de dividendos	1,18%
Dividendos TTM	€ 0,0195
Próximo dividendo	€ 0,0124
Beta	0,32
PER (PE Ratio)	42,69
PEG (PEG Ratio)	0,49
P/VC (PB Ratio)	6,06
P/V (PS Ratio)	2,80

Perfil da empresa

Sigma Healthcare Limited ist zusammen mit seinen Tochtergesellschaften im Großhandel und Vertrieb von pharmazeutischen Produkten hauptsächlich in Australien tätig. Das Unternehmen betreibt rund 1.200 Markenapotheken und unabhängige Apotheken unter den Marken Amcal, Discount Drug Stores, Guardian, WholeLife und PharmaSave. Darüber hinaus bietet das Unternehmen Großhandelsdienstleistungen für Krankenhausapotheken, Hilfsdienste für die Verabreichung von Arzneimitteln in der Altenpflege, in Gemeindeapotheken und im häuslichen Bereich, Technologielösungen und Datenanalysen sowie Produktentwicklung und -unterstützung für eine Reihe von Eigen- und Exklusivmarkenprodukten an und liefert medizinische Verbrauchsmaterialien und Geräte an eine breite Palette von Kunden, darunter Apotheken, Altenpflegeeinrichtungen, Krankenhäuser und Kliniken. Darüber hinaus bietet das Unternehmen pharmazeutischen Herstellern und anderen Lieferpartnern Kontraktlogistikdienste an. Sigma Healthcare Limited wurde 1912 gegründet und hat seinen Hauptsitz in Rowville, Australien.